| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f984722d0e992d9a5fcc6d63beb24199
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eea137d43022908bdf58f3f6a13bfaf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da52351dae7b49dec112d5be311b226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d17fabe55afd9e3254928d0f66ac4f02 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-141111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-6417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-6421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-142222 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-274 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 |
| filingDate |
2008-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0013c555671157afeb28ce17c77b4c76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2f6b646550e26c0cf30fce7768c3271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdcc239de4edcfb65f3153a4597edaac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95058959d99d8d4b0cf45f2536603ef8 |
| publicationDate |
2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011151570-A1 |
| titleOfInvention |
Method for on-site drug detection in illicit drug samples |
| abstract |
The invention is provided for detection of Heroin and Morphine in illicit drug samples, also for their differentiation. A liquid sample from a street sample is prepared and divided into two equal aliquots, one of them being reference sample, another being main sample. Both samples are treated with Hydrochloric acid and Sodium hydroxide, but those substances are added to the samples in the different sequence. After that the measurement of SFS of the reference sample is performed. Further the presence of specific spectral pattern of Morphine in the measured SFS of the reference, sample is detected and the value of SFS intensity at the specific spectral point is fixed (a reference value). After 15 minutes for acidification of the main sample, the analogous measurement and detection of the Morphine in the main sample are performed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019095206-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9759733-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10330603-B1 |
| priorityDate |
2008-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |